Dividend-News

Daily dividend news for investors in dividend stocks


Roche Is A Suitable Addition To Diversified Dividend Growth Portfolios

Published Tue, 22 Dec 2020 14:32:55 -0500 on Seeking Alpha

Seeking AlphaDividend Ideas | Healthcare  | SwitzerlandRoche Is A Suitable Addition To Diversified Dividend Growth PortfoliosDec. 22, 2020 2:32 PM ET|| About: Roche Holding AG (RHHBY), Includes: JNJby: Khen ElazarKhen Elazar Value, Dividend Growth InvestingSummaryI was looking at the healthcare sector for ideas lately.
After I analyzed Abbott and Owens & Minor, I decided to go international.
Roche is one of the largest healthcare companies in the world, and many times overlooked.
Introduction
The healthcare sector gets plenty of attention lately in the media, and among many Seeking Alpha authors, myself included. Covid-19 is still the largest single event to affect our economy and way of life. I personally analyzed Abbott Laboratories (ABT) and Owens & Minor (OMI) in the last week alone.
In this article, I will cross the Atlantic Ocean and will visit Switzerland. I will look into Roche (OTCQX:RHHBY), which is one of the largest healthcare companies in the world with a market cap of $300 billion. I sometimes find hidden value in international stocks, as they are overlooked by many American investors. I find it with Unilever (UL) as well as Nestlé (OTCPK: NSRGY).
In this article, I will analyze Roche using the graph below. I use the same methodology when I analyze dividend growth stocks. The reason I do it is so I can have a reliable comparison between investment options. I will look into the fundamentals, the valuation, the growth opportunities and the risks, and try to determine whether Roche is a decent addition to your dividend growth portfolio.

(Graph made by author)
According to Seeking Alpha company overview, Roche engages in the prescription pharmaceuticals and diagnostics businesses. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis, HIV/AIDS, and more. The company also offers in vitro diagnostics solutions for indications. In addition, it supplies... Read more

Stock name Last trade   P/E Earnings/Share Dividend/Share Dividend yield
JOHNSON & JOHNSON 130.43   21.6 6.03 3.80 2.93

JOHNSON & JOHNSON - JNJ
JOHNSON & JOHNSON - JNJ  


Older articles featuring Johnson & Johnson (JNJ):
Johnson & Johnson: A Top Dividend Stock for 2021 & Beyond
31 December Dividend Stocks Billionaires Hold
Revisiting Yield Channel Charts
Nicholas Ward's Dividend Growth Portfolio: November 2020 Review
Dividend Champion And Contender Highlights: Week Of December 6
Johnson & Johnson: 3 Reasons to Check Out This Dividend Giant Now
All Weather Dividends: 10 Value Buys And 5 Overvalued Sells To End 2020
Of 56 Kiplinger Outstanding Dividend Stocks, 11 Show Sweetness For December
Vanguard High Dividend Yield ETF: Rotation From Growth Into Value Stocks Should Boost Investor Appetite For This ETF
6 Wonderful Black Friday Dividend Aristocrat Deals

More